Results
Of the 294 patients initially enrolled in the study,
42 dropped out for various extraneous reasons, for
example lack of quick result, long travel time to
come to the clinic and migration to other parts
of China.
The
patient age distribution is given in figure 1.
The majority of patients were aged between 21
and 30 years. There were 81patients who were 18
years or below.
As
seen in figure 2, most of the patients had psoriasis
for more then two years. One patient suffered
from psoriasis for 38 years.
Sixty-three
patients had not previously taken steroids or
immunosuppressive drugs (Group 1), while 189 patients
had a history of intake of such drugs (Group 2).
After
3 months of treatment, 60 patients in Group 1
(Figure 3) experienced a complete healing of their
psoriasis lesions and no relapse was seen during
the subsequent follow-up period of up to 8 years.
In
this group, about a week after the first intake
of the capsules, new lesions ceased to appear
and old lesions started to improve, until complete
disappearance. Upon recovery, the (previously)
affected skin area had a normal appearance and
took on the color of healthy skin.
After
9 months of treatment, 164 patients in Group 2
experienced a complete healing with no relapse
during the subsequent follow-up period of up to
8 years. This worked out to an 87% success rate.
In
this group, after about 2 weeks of treatment,
new lesions ceased to appear while after 1 month
(of treatment), the old lesions reduced in size
and become greyish.
The
improvements of the symptoms began in the lower
limbs, gradually moving upwards during the course
of the treatment. A small number of patients saw
an improvement in all parts of the body at the
same time.
Ten
patients complained about adverse events (headache,
diarrhea, nausea) which were considered by the
investigator not to be related to the study drug
treatment received. None of the patients stopped
the treatment because of these adverse events.
The
success rate percentage was the same in children
as in adults. There was also no difference in
success rate between men and women.
Clinical
Study
